Work

SAT0130 Long-term safety of adalimumab in patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, and crohn's disease

Year: 2012

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2012-eular.3077

Authors: G.R. Burmester, R. Panaccione, K.B. Gordon, M.J. McIlraith, A. Lacerda

Institutions: Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, University of Calgary, Northwestern University, Abbott (France), Abbott (Brazil)

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2332829298

Cites:

Cited by: 13

Related to: 10